Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.
Gilead Sciences GILD has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.
Celgene CELG has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.
Alexion Pharmaceuticals ALXN has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.
Biogen Idec BIIB has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in